H.R. 979 (112th): FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act

Introduced:
Mar 09, 2011 (112th Congress, 2011–2013)
Sponsor:
Rep. Stephen Lynch [D-MA9]
Status:
Died (Referred to Committee)
See Instead:
This bill was re-introduced as H.R. 1367 on Mar 21, 2013. See H.R. 1367 for current action on this subject.

The bill’s title was written by the bill’s sponsor. H.R. stands for House of Representatives bill.

(About Ads | Advertise Here)
Status

This bill was introduced on March 9, 2011, in a previous session of Congress, but was not enacted.

Progress
Introduced Mar 09, 2011
Referred to Committee Mar 09, 2011
Cosponsors
7 cosponsors (6D, 1R) (show)
Committees

House Oversight and Government Reform

The committee chair determines whether a bill will move past the committee stage.

Full Title

To amend chapter 89 of title 5, United States Code, to ensure program integrity, transparency, and cost savings in the pricing and contracting of prescription drug benefits under the Federal Employees Health Benefits Program.

Summary

No summaries available.

Text

Read Bill Text »

Last updated Mar 09, 2011.
19 pages

Primary Source

View on THOMAS (The Library of Congress)

GovTrack gets most information from THOMAS, which is updated generally one day after events occur. Activity since the last update may not be reflected here.

Citation

Click a format for a citation suggestion:

GovTrack’s Bill Summary

We don’t have a summary available yet.

Library of Congress Summary

The summary below was written by the Congressional Research Service, which is a nonpartisan division of the Library of Congress.

3/9/2011--Introduced.
FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act - Prohibits the Office of Personnel Management (OPM) from entering a contract or approving a health benefits plan with a carrier that is a party to a pharmacy benefit manager (PBM) carrier arrangement to provide or administer prescription drug coverage under the Federal Employees Health Benefits Program (FEHBP) unless the PBM and the carrier comply with the requirements for PBM carrier arrangements set forth by this Act. Directs OPM to terminate a contract or discontinue a plan that fails to comply with such requirements.
Prohibits:
(1) a PBM under a carrier arrangement from being under common corporate control with a prescription drug manufacturer or a retail pharmacy, and
(2) OPM from permitting a carrier under common corporate control with a PBM to earn a profit from such control.
Sets forth terms and requirements for PBM carrier arrangements under the FEHBP, including:
(1) drug substitution restrictions,
(2) PBM reimbursement of carriers,
(3) sale by a PBM of utilization and claims data,
(4) drug pricing and the basis for reimbursement,
(5) PBM provision to plan enrollees of an explanation of benefits statement regarding prescription drugs,
(6) nondiscriminatory contracts regarding required participation,
(7) OPM access to PBM contract information, and
(8) civil monetary penalties for making false statements or claims to the government.

House Republican Conference Summary

The summary below was written by the House Republican Conference, which is the caucus of Republicans in the House of Representatives.

No summary available.

House Democratic Caucus Summary

The House Democratic Caucus does not provide summaries of bills.

So, yes, we display the House Republican Conference’s summaries when available even if we do not have a Democratic summary available. That’s because we feel it is better to give you as much information as possible, even if we cannot provide every viewpoint.

We’ll be looking for a source of summaries from the other side in the meanwhile.

The bill contains the following citations to other parts of U.S. law:

United States Code

The United States Code is the compilation of permanent laws enacted by Congress. Temporary and other non-permanent laws do not appear in the United States Code. (About half of the United States Code is the law itself, called positive law. The other half is merely a compilation of the laws but has no legal significance.)

  • Title 5: GOVERNMENT ORGANIZATION AND EMPLOYEES
  • Part III: EMPLOYEES
  • Subpart G: Insurance and Annuities
  • Chapter 89: HEALTH INSURANCE
  • Section 8902: Contracting authority
  • Title 21: FOOD AND DRUGS
  • Chapter 9: FEDERAL FOOD, DRUG, AND COSMETIC ACT
  • Subchapter V: DRUGS AND DEVICES
  • Part A: Drugs and Devices
  • Section 355: New drugs
  • Other Citations
  • 5 U.S.C. 8915

Other Citations

  • 5 U.S.C. Chapter 89